Cardlytics Q3 2023 Earnings Presentation
21
Reconciliation of GAAP net (loss) income
to non-GAAP net income (loss)
and non-GAAP net income (loss) per share
Net (loss) income
Plus:
Stock-based compensation expense
Foreign currency (gain) loss
Acquisition and integration (benefit) cost
Amortization of acquired intangibles
Loss (gain) in fair value of contingent consideration
Goodwill impairment
Restructuring and reduction of force
Income tax benefit
Non-GAAP net income (loss)
Weighted-average number of shares of common stock used in computing non-GAAP net income (loss) per share:
Weighted-average ommon shares outstanding, diluted
Non-GAAP net income (loss) per share attributable to common stockholders, diluted
Three Months Ended
September 30,
2023
($23,966)
10,249
2,399
(78)
3,433
8,281
$318
37,982
$0.01
2022
$6,267
5,767
4,673
(1,867)
7,207
(46,126)
7,530
($16,549)
33,269
($0.50)
(Amounts in thousands, except per share amounts)
Nine Months Ended
September 30,
2023
($33,866)
29,956
(379)
8,146
10,331
(15,045)
($857)
35,502
($0.02)
2022
($86,985)
32,194
10,882
(4,269)
21,560
(114,144)
83,149
8,488
(1,446)
($50,571)
33,455
($1.51)View entire presentation